Skip to content

Transthoracic Echocardiography of Ventricular Function of Parturients in Labor

Transthoracic Echocardiography of Cardiac Function of Parturients in Labor

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04481503
Enrollment
150
Registered
2020-07-22
Start date
2020-09-05
Completion date
2024-05-01
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases in Pregnancy, Cardiovascular Risk Factor, Obstetric Labor Complications

Brief summary

This echocardiography study will characterize heart structure and function during labor. Imaging of the heart during the stress of labor could increase detection of subclinical cardiovascular disease using advanced imaging techniques. Cardiac serum biomarkers and complication rates will also be measured and compared between patients with and without evidence of cardiovascular disease on echocardiography.

Interventions

None listed

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* All healthy parturients 18 years of age or older with estimated gestation greater than or equal to 37 weeks who are expected to deliver during their hospitalization. * During the echocardiographic exam, the patient must be in active labor with cervical dilation between 6-10 cm and contractions that are spaced less than 5 minutes apart.

Exclusion criteria

* Known functional or structural heart disease * Previously diagnosed pulmonary hypertension. * Comorbid disease other than diet controlled gestational diabetes, uncomplicated obesity, mild asthma and euthyroid patients with a history of hypo or hyperthyroidism. * Parturients endorsing active use of non-prescription mind-altering drugs including cocaine, methamphetamine, or ketamine. * Other non-inclusion criteria include inability to tolerate left lateral positioning either symptomatically or by fetal heart rate monitoring, suspected hypo-or hypercoagulable states that was not previously diagnosed, hemodynamic instability requiring \>2 L crystalloid administration within 1 hour time frame after epidural placement or vasopressor administration of \>15 mg ephedrine or \>300 mcg phenylephrine administration within 1 hour after epidural placement.

Design outcomes

Primary

MeasureTime frameDescription
The proportion of patients with an abnormal strain pattern as compared to parturients not in laborDuring echocardiogram procedureLeft ventricular strain
The proportion of patients with diastolic dysfunction as compared to parturients not in laborDuring echocardiogram procedureAbnormal diastolic function

Secondary

MeasureTime frameDescription
Estimated right ventricular systolic pressureDuring echocardiogram procedureComparing estimated right ventricular systolic pressure between patients in active labor as compared to those who are not in active labor (mm Hg)

Other

MeasureTime frameDescription
Left ventricular myocardial performance indexDuring echocardiogram procedure
Total number of patients with the presence of regional wall motion abnormalitiesDuring echocardiogram procedure
Total number of patients with abnormal global right ventricular dysfunctionDuring echocardiogram procedure
Right ventricular strainDuring echocardiogram procedure%
Tricuspid annular plane systolic excursionDuring echocardiogram procedurecentimeters
The number of patients with an identifiable Centers for Disease Control Severe Maternal Morbidity Identification complication post-partum0 to 42 days post-partumAcute myocardial infarction, aortic aneurysm, acute renal failure, adult respiratory distress syndrome, amniotic fluid embolism, cardiac arrest, ventricular fibrillation, conversion of cardiac rhythm, disseminated intravascular coagulation, eclampsia, heart failure, arrest during surgery or procedure, puerperal cerebrovascular disorders, pulmonary edema, aspiration, cardiopulmonary anesthesia complications, sepsis, shock, air or thrombotic embolism, blood product transfusion, hysterectomy, temporary tracheostomy, requiring ventilation
The number of patients with a pulse oximetry reading <90% after delivery0 to 42 days post-partum
The number of patients who required oxygen administration after delivery0 to 42 days post-partum
The number of patients who develop atrial fibrillation or premature atrial complexes0 to 42 days post-partum
The number of patients who develop a stroke0 to 42 days post-partumStroke must be verified by imaging including either computed tomography or magnetic resonance imaging.
The number of patients with an elevation in transaminase levels during labor or after delivery0 to 42 days post-partum
Tissue doppler s'During echocardiogram procedurecm/sec
The number of patients requiring intensive care unit admission within 42 days post delivery0 to 42 days post-partum
Mortality within 42 days post delivery0 to 42 days post-partum
The number of patients with a post-partum diagnosis of post-partum hemorrhage0 to 42 days post-partum
The total number of patients who require additional uterotonic medications other than oxytocin after delivery0 to 42 days post-partumMedications include additional dosage of oxytocin above 3 units, methylergonovine, carboprost, tranexamic acid or misoprostol
The number of patients requiring a transfusion0 to 42 days post-partumCell Saver, red blood cells, platelets, fresh frozen plasma, cryoprecipitate
Blood loss0 to 42 days post-partumEstimated and quantitated blood loss as well as the difference between pre-delivery hemoglobin and post-delivery lowest hemoglobin during admission
Number of patients requiring vasopressor after delivery to support blood pressure0 to 42 days post-partumphenylephrine, ephedrine, norepinephrine, epinephrine, vasopressin, inhaled nitrous oxide, inhaled epoprostenol
Activin A levelLess than 3 hours after echocardiogram procedure
Placental Growth FactorLess than 3 hours after echocardiogram procedure
Soluble endoglinLess than 3 hours after echocardiogram procedure
Hospital length of stay0 to 42 days post-partumTotal hours from admission to discharge
Total number of maternal deaths within 0-42 days post-partum0 to 42 days post-partum
Left ventricular systolic functionDuring echocardiogram procedureSimpson's method of discs motion abnormalities and diastolic function

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026